Published in
Taylor and Francis Group, Expert Opinion on Pharmacotherapy, 2(24), p. 259-265, 2022
DOI: 10.1080/14656566.2022.2150965
Links
Tools
Imlifidase therapy: exploring its clinical uses
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 